Industry Insights
-
Deciphering FDA's 7-Step Framework For AI-Driven Decision-Making
2/27/2025
The draft framework, published in January, aims to ensure that AI systems used in drug development are robust, reliable, and aligned with regulatory expectations.
-
Strengthening Shop-Floor QA From The Ground Up
2/24/2025
Quality is created where and when manufacturing happens, not later through inspection. This approach integrates the QA function into daily production operations.
-
9 Reasons Why You Should Consider AI In Analytical Instrument Qualification
2/21/2025
AI is about to completely change the analytical instrument qualification (AIQ) landscape in the pharma/biopharma and medical device industries.
-
10 Ways To Speed Up CMC In Early-Stage Drug Product Development
2/21/2025
The inherent complexity of living cell-based products, vector-based gene therapies, and highly sensitive analytical methods demands robust change management strategies.
-
Challenges And Opportunities Of Outsourcing Biopharma Development
2/19/2025
Oversight, knowledge management, and operational/compliance risk make up the three key challenge classifications to consider when approaching a new outsourcing agreement.
-
Consumables Are Leading The Cleanroom Market — Here's Why
2/19/2025
As the industry expands, so, too does demand for PPE. This market analysis looks at the trends in consumables and other cleanroom technology used to make medicine.
-
What Do We (Really) Know About DNA Quality For In Vitro Transcription?
2/19/2025
Gene therapies and nucleic acid medicines are dependent upon a starting DNA template that defines the protein or antigen. The sequence of this template DNA being correct is critical.
-
Comparison Of WFI Production Methods: Multi-Effect Distillation Vs. Vapor Compression
2/18/2025
The two most common hot water for injection (WFI) generation methods are multi-effect distillation (MED) and vapor compression (VC). There are significant differences in terms of operational principles and energy efficiency.
-
Managing Contamination Risks In The Pharmaceutical And Medical Device Industries Using Relational Risk Analysis
2/18/2025
Of all the risks associated with pharmaceuticals and medical devices, controlling contamination is one of the most important and difficult challenges. Relational risk analysis (ReRA) can help.
-
Legend's CARVYKTI Offers Lessons In Commercial-Phase Changes
2/14/2025
The company is starting small with a pilot to do what most companies avoid altogether — innovating the manufacturing process for a product already on the market.